Efficacy and tolerability of the anti-inflammatory throat lozenge flurbiprofen 8.75mg in the treatment of sore throat a randomised, double-blind, placebo-controlled study

Clinical Drug Investigation

Volumn 21, Issue 3, 2001, Pages 183-193

  Benrimoj, S I ^a   Langford, J H ^a   Christian, J ^b   Charlesworth, A ^c   Steans, A ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b The Boots Company PLC   (United Kingdom)

^c Nottingham Clinical Research Group   (United Kingdom)

^d Boots Healthcare Australia Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; FLURBIPROFEN; PLACEBO;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; LOZENGE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SORE THROAT; TASTE DISORDER; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VERTIGO;

EID: 0035091582     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121030-00004     Document Type: Article

References (28)

1. Pharyngitis
2. Controversies in management: Are antibiotics appropriate for sore throats? Costs outweigh the benefits
3. Managing sore throat: A literature review II. Do antibiotics confer benefit?
4. Penicillin in sore throat
5. Open randomised trial of prescribing strategies in managing sore throat
6. Reducing antibiotics for respiratory tract symptoms in primary care: Consolidating 'why' and considering 'how'
7. New mechanisms of bacterial resistance to antimicrobial agents
8. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: The medicalising effect of prescribing antibiotics
9. Clinical safety of flurbiprofen
10. A long-term study of flurbiprofen in rheumatological disorders. I. Rheumatoid arthritis
11. A long-term study of flurbiprofen in rheumatological disorders. II. Osteoarthritis
12. A long-term study of flurbiprofen in rheumatological disorders. III. Other articular disorders
13. Efficacy comparisons of flurbiprofen with other nonsteroidal anti-inflammatory drugs in arthritic diseases
14. Controlled study on flurbiprofen and diclofenac in the treatment of rheumatic disorders
15. Variability in response to nonsteroidal anti-inflammatory analgesics: Evidence from controlled clinical therapeutic trial of flurbiprofen in rheumatoid arthritis
16. European experience with flurbiprofen. A new analgesic/anti-inflammatory agent
17. The use of topical flurbiprofen as an adjunct to non-surgical management of periodontal disease
18. The evaluation of the analgesic and anti-inflammatory effects of flurbiprofen mouthwash and 100 mg tablets in oral medicine
19. Flurbiprofen collutory in oral surgical pathology
20. Pharmacological support during orthodontic therapy with a topical anti-inflammatory
21. Demonstration of dose-response of flurbiprofen lozenge for sore throat
22. Local and general tolerability of flurbiprofen lozenges in healthy volunteers
23. A placebo-controlled model to assay the onset of action of nonprescription-strength analgesic drugs
24. Sore throat pain in the evaluation of mild analgesics
25. Subjective and objective features of sore throat